Olema Pharmaceuticals, Inc. (OLMA)
NASDAQ: OLMA · IEX Real-Time Price · USD
-0.41 (-3.19%)
Jun 13, 2024, 4:00 PM EDT - Market closed

Olema Pharmaceuticals Statistics

Total Valuation

OLMA has a market cap or net worth of $696.94 million. The enterprise value is $455.20 million.

Market Cap 696.94M
Enterprise Value 455.20M

Important Dates

The next estimated earnings date is Tuesday, August 6, 2024, after market close.

Earnings Date Aug 6, 2024
Ex-Dividend Date n/a

Share Statistics

OLMA has 55.93 million shares outstanding. The number of shares has increased by 37.72% in one year.

Shares Outstanding 55.93M
Shares Change (YoY) +37.72%
Shares Change (QoQ) +22.82%
Owned by Insiders (%) 3.81%
Owned by Institutions (%) 99.76%
Float 29.46M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio n/a
Forward PS n/a
PB Ratio 2.97
P/FCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 9.61, with a Debt / Equity ratio of 0.01.

Current Ratio 9.61
Quick Ratio n/a
Debt / Equity 0.01
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage n/a

Financial Efficiency

Return on equity (ROE) is -42.90% and return on invested capital (ROIC) is -45.99%.

Return on Equity (ROE) -42.90%
Return on Assets (ROA) -39.30%
Return on Capital (ROIC) -45.99%
Revenue Per Employee n/a
Profits Per Employee -$1.32M
Employee Count 75
Asset Turnover n/a
Inventory Turnover n/a


Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has increased by +35.14% in the last 52 weeks. The beta is 2.05, so OLMA's price volatility has been higher than the market average.

Beta (1Y) 2.05
52-Week Price Change +35.14%
50-Day Moving Average 10.69
200-Day Moving Average 12.38
Relative Strength Index (RSI) 58.00
Average Volume (30 Days) 1,028,452

Short Selling Information

The latest short interest is 8.17 million, so 14.61% of the outstanding shares have been sold short.

Short Interest 8.17M
Short Previous Month 8.54M
Short % of Shares Out 14.61%
Short % of Float 27.73%
Short Ratio (days to cover) 11.50

Income Statement

Revenue n/a
Gross Profit n/a
Operating Income -109.70M
Pretax Income -99.34M
Net Income -99.34M
EBITDA -97.72M
EBIT -99.34M
Earnings Per Share (EPS) -$2.01
Full Income Statement

Balance Sheet

The company has $248.98 million in cash and $2.21 million in debt, giving a net cash position of $246.77 million or $4.41 per share.

Cash & Cash Equivalents 248.98M
Total Debt 2.21M
Net Cash 246.77M
Net Cash Per Share $4.41
Equity / Book Value 236.32M
Book Value Per Share 4.22
Working Capital 225.87M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$86.83 million and capital expenditures -$139,000, giving a free cash flow of -$86.97 million.

Operating Cash Flow -86.83M
Capital Expenditures -139,000
Free Cash Flow -86.97M
FCF Per Share -$1.57
Full Cash Flow Statement


Gross Margin n/a
Operating Margin n/a
Pretax Margin n/a
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

OLMA does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -37.72%
Shareholder Yield -37.72%
Earnings Yield -14.15%
FCF Yield -12.39%

Analyst Forecast

The average price target for OLMA is $22.80, which is 82.99% higher than the current price. The consensus rating is "Strong Buy".

Price Target $22.80
Price Target Difference 82.99%
Analyst Consensus Strong Buy
Analyst Count 5
Revenue Growth Forecast (5Y) n/a
EPS Growth Forecast (5Y) n/a
Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a


Altman Z-Score n/a
Piotroski F-Score 2